ABSTRACT
Studies have shown a time-dependent loss of immunoreactivity with a variety of diagnostic, prognostic, and predictive antibodies used on unstained slides prepared from formalin-fixed, paraffin-embedded tissue blocks. Diminished epitope detection on stored slides was described in a landmark observation. [1] [2] [3] A follow-up study on breast cancer cases showed significant loss of estrogen receptor (ER), BCL-2, and factor VIII-related antigen (von Willebrand factor) after 12 weeks of storage. 4 Multiple factors affect epitope detection and interpretation, including fixation type and time, retrieval method, and specifics of the antibody clone, including mono-or polyclonality and species in which the antibody was raised. 5, 6 Storage factors may cause loss of integrity of the epitope due to various factors, including temperature, light, and air exposure. A large study of epitope stability examined 20 monoclonal and 12 polyclonal antibodies on precut slides stored at 4°C, 21°C, and 37°C at time periods ranging from 2 to 52 weeks. 7 Overall, 34% of their immunohistochemical results were altered with storage at 21°C compared with 12% affected at lower temperatures (4°C). Specifically, storage of slides at 21°C affected detection of adrenocorticotropic hormone, Her2, p53, BCL-2, ER, progesterone receptor, E-cadherin, keratin, vimentin, CD45 RO, and CD31 epitopes. Interestingly, the effects of storage on ER, BCL-2, and factor VIII-related antigen immunoreactivity were not as deleterious as those reported in an earlier analysis, 4 due at least in part to a change in antibody clone (ER) and different tissue fixation (10% formalin vs 10% formalin + 70% ethanol in Jacobs et al 4 study). In a study of slides stored up to 10 years, Bertheau and colleagues 8 also observed significantly decreased staining for ER, CD3, and chromogranin antibodies. Because of different laboratory preanalytic and analytic variables, it is difficult to draw definitive comparisons among studies; for example, the study by DiVito et al 9 of ER on precut and stored slides showed a useful level of epitope detection for only 6 days, while Williams et al 10 noted persistent reactivity at 6 months, in part reflecting use of tape transfer to adhesive slides, different formalin fixation times, and antibody clones. 11 Despite some challenges in generalizing these observations, these studies provide evidence that accurate clinical care and meaningful research based on immunohistochemical techniques require thoughtful consideration of storage conditions for precut slides. However, for optimal tissue microarray (TMA) use and to limit tissue loss, TMA blocks often may be cut all at once. 12 The Biospecimen Reporting for Improved Study Quality group 13 recommends reporting details of storage conditions of such biospecimens, including temperature, duration, freeze/thaw cycles, shipping parameters, and other details. Recent recommendations 14 suggest a storage temperature as low as possible (-80°C), protection from light, and vacuum packing with desiccant to protect against protein degradation. We sought to test the effect of various storage conditions, including those recommended by the Canadian Association of Pathologists guidelines, 14 on epitope detection over time. We specifically chose immunohistochemical markers with prognostic, predictive, and diagnostic value, where loss of epitope detection has tangible clinical implications.
Materials and Methods
Our study, designed to assess common storage conditions in a time-dependent manner, was influenced by recent Canadian Association of Pathologists guidelines.
14 A TMA was constructed using routinely prepared formalin-fixed, paraffin-embedded blocks of human neoplasms, including five gliomas (grades II-IV), six prostatic adenocarcinomas (Gleason grades 3 + 4 [1] , 3 + 4 + 5 [2] , 4 + 3 + 5 [2] , 4 + 5 [1] ), four urothelial carcinomas with high-grade neuroendocrine (small cell) differentiation, and two lung control tissues. Since variability in staining is expected at different levels of the TMA, we intentionally selected more homogeneous neoplasms. From each case, two tissue cylinders with a diameter of 1 mm (total 27 cores) were arrayed into a recipient block using a manual tissue microarrayer MTA (Beecher Instruments, Sun Prairie, WI). Serial 4-µm sections of the TMA block(s) were mounted on glass slides in sufficient numbers to support the protocols that follow. Five slides from each block were immediately stained with five antibodies: p53, Ki-67, androgen receptor (AR), synaptophysin, and mutant isocitrate dehydrogenase 1 (IDH-1).
The immunohistochemical stains were prepared in a College of American Pathologists-accredited diagnostic immunohistochemistry laboratory using standardized protocols. In brief, 4-µm tissue array sections were deparaffinized on a fully automated immunostainer (Bond III; Leica Biosystems, Wetzlar, Germany) using a proprietary Bond dewax solution that contains no xylene. There were three applications of the Dewax solution followed by three applications of 100% ethanol and then three applications of Bond wash solution. Antigen retrieval was performed on a Bond III using either ER1 (citrate with a pH range of 5.9-6.1) or ER2 (EDTA with a pH range of 8.9-9.1) buffers for 20 minutes. After rinsing and endogenous peroxidase blocking, a postprimary immunoglobulin G (IgG) linker was applied, followed by several rinses with the Bond wash solution and a deionized water rinse. The slides were incubated for 15 minutes with one of five primary mouse monoclonal antibodies and rinsed multiple times with Bond wash solution. Then, a polymer anti-mouse poly-horseradish peroxidase-IgG was applied and slides were incubated for 8 minutes with polymer detection reagent (Bond Polymer Refine Detection kit; Leica Biosystems), then rinsed multiple times. 3,3′-Diaminobenzidine tetrahydrochloride chromogen was allowed to precipitate for 10 minutes, and then slides were counterstained with hematoxylin for 5 minutes. The same antibody lot was used for all data points throughout both portions of the experiment for AR, synaptophysin, and p53. For IDH-1 and Ki-67, one antibody lot was used for the all data points in the ambient air experiment, and another antibody lot from the same manufacturer was used for all data points in the vacuum-sealing experimental portion. Detailed information on antibodies and epitope retrieval conditions used is shown in ❚Table 1❚.
In the first portion of this experiment, the remaining slides were separated, stored, and subsequently stained at predetermined time intervals as follows: room temperature (RT) exposed to air, refrigerated at 4°C exposed to air, and frozen at -20°C exposed to air; for each storage condition, slides were stained at time 0, 1 week, 2 weeks, 4 weeks, 6 weeks, 12 weeks, 24 weeks, and 52 weeks. One additional slide for each marker was cut and stored with a paraffin coating at RT and stained at week 52. After initial results were reviewed, a second TMA was made and time-dependent protocols similar to those described above were performed as described above but with different storage conditions. For the second portion, after time 0 slides were cut and stained, the remaining slides were separated, stored, and subsequently stained at predetermined time periods as follows: RT with paraffin coating, RT with vacuum sealing, -20°C with vacuum sealing, and
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Stained slides were reviewed manually, then scanned at ×20 and evaluated with image analysis software (Aperio, Leica Biosystems), using a nuclear or cytoplasmic algorithm as appropriate. Overall intensity (0 to 3+) and percentage of cells staining for each available TMA core were assessed, and an H-score was calculated by computing the sum of the products of each intensity score multiplied by the percentage of cells staining at that level of intensity. 15 Statistical analysis was performed in GraphPad Prism 6 (GraphPad Software, La Jolla, CA) using nonparametric Mann-Whitney tests. Data points that showed evidence of artifactual image analyses-such as scoring of pigment or noncellular staining-were excluded.
Results
When all storage conditions were considered, the degree of epitope preservation at approximately 1 year (52-55 weeks) compared with time 0 expression ranged from 1.4% (p53, paraffin coated, and kept at RT) to 186% (IDH-1, vacuum sealed, and stored at -80°C). Compared with time 0, the overall median percentage immunoreactivity was 66% at 6 months (P < .0001) and 51% at 1 year (P < .0001 vs time 0 and P = .0639 vs 6 months). Over the course of the experiment, the overall median percentage epitope detection was 55% for precut slides stored in paraffin coating, 73% for RT, 75% for 4°C, 87% for -20°C, and 71% for those stored at -80°C. Comparing ambient air vs vacuum sealing, the overall median percentage epitope detection was 76% for vacuum sealing and 75% for exposure to air. There was great variability among antibodies. Results for each antibody, storage condition, and time point are shown in ❚Figure 1❚, ❚Image 1❚, ❚Table 2❚, ❚Table 3❚, ❚Table 4❚, ❚Table 5❚, and ❚Table 6❚. Results are expressed as percentage of the time 0 value, with this value determined by taking the median of the H-scores for each of 27 tissue cores in the TMA.
AR
At approximately 1 year, the degree of epitope preservation compared with time 0 expression ranged from 18% (paraffin coated and kept at RT) to 70% (-20°C, vacuum sealed) (Table 2, Figure 1 , and Images 1A and 1B). Through the experiment for slides exposed to air, epitope detection for AR was preserved for all storage conditions through week 24. At week 52, the precut slide preserved in the refrigerator at 4°C showed a trend toward loss of immunoreactivity compared with time 0 (41% of original; P = .0625); other storage conditions and time points showed losses that did not reach statistical significance. On slides that were vacuum sealed, epitope detection for AR was preserved for all storage conditions through week 12. At week 24, the precut slide preserved with paraffin coating showed loss of immunoreactivity compared with time 0 (15% of original; P = .0001) as did the one stored at RT (27% of original; P = .05); those that were vacuum sealed and stored at -20°C and -80°C showed loss (35% and 43% of original, respectively), which did not reach statistical significance. At week 55, there was significant loss of immunoreactivity for paraffin coating (18% of original; P = .0007), RT (25% of original; P = .044), and -80°C (27% of original of original P = .05) but not -20°C (70% of original). In manual review, the loss of immunoreactivity for AR presented as progressively decreased staining intensity.
p53
At approximately 1 year, the degree of epitope preservation compared with time 0 expression ranged from 1.4% (paraffin coated and kept at RT) to 66% (-20°C, without vacuum seal) (Table 3, Figure 1 , and Images 1C and 1D). In the experiment for slides stored exposed to air, variable losses in epitope detection were seen through week 6. Beginning at 12 weeks, significant loss of immunoreactivity was first seen for slides stored in the refrigerator at 4°C compared with time 0, which continued through the 
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AJCP / Original article remainder of the experiment (week 12: 29% of original, P = .0135; week 24: 33% of original, P = .0043; weeks 52-55: 13% of original, P = .0005). Starting at 24 weeks, slides stored at room temperature also showed loss of immunoreactivity compared with time 0 (week 24: 42% of original, P = .0327; week 52: 29% of original, P = .0054).
In contrast, for vacuum-sealed slides, all storage conditions showed significant loss of immunoreactivity beginning at week 1. At approximately 1 year, only slides frozen at -20°C and exposed to air were without significant loss of immunoreactivity (66% of original; P = .249). In manual review, loss of p53 immunoreactivity also manifested in progressively decreased staining intensity rather than as abrupt decreases in the number of cells staining.
Ki-67
At approximately 1 year, the degree of epitope preservation compared with time 0 expression ranged from 37% (paraffin coated and kept at RT) to 92% (vacuum sealed, -20°C) (Table 4, Figure 1 , and Images 1E and 1F). In precut slides exposed to air, at weeks 52 to 55, the median H-score for the entire TMA dropped to 62% for those stored at RT, 68% for slides stored in the refrigerator, and 78% for those stored at -20°C compared with time 0; none
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AJCP / Original article of these were statistically significant. For vacuum-sealed slides at 1 year, epitope detection was 65% of original for slides stored at RT, 92% for those at -20°C, and 86% for those at -80°C. Paraffin coating showed significant loss of staining at weeks 52 to 55 (37% of original; P = .0091).
Synaptophysin
At approximately 1 year, the degree of epitope preservation compared with time 0 expression ranged from 42% (paraffin coated and kept at RT) to 81% (-20°C, without vacuum seal) ( Table 5 ). In vacuum-sealed slides, storage at -20°C or -80°C preserved antigenicity through 1 year (57% and 71% of original, respectively). Significant loss of epitope detection was seen at week 55 for the slide stored at RT (39% of original P = .0091) and starting at approximately 6 months for those that were paraffin coated (week 24: 48% of original, P = .0181; weeks 52-55: 42% of original, P = .005).
IDH-1
At approximately 1 year, the degree of epitope preservation compared with time 0 expression ranged from 17% (RT without vacuum seal) to 186% (-80°C, vacuum sealed) ❚Table 6❚, (Figure 1 , and Images 1G and 1H). Through the experiment for slides exposed to air, IDH-1 showed significant loss of epitope detection first seen at week 6 for slides stored at RT and 4°C, whereas those stored at -20°C had preserved antigenicity at week 6. By week 12, all storage conditions showed significant loss of epitope detection, which persisted through weeks 24 and 52 to 55. At 1 year, this was most notable for slides stored at RT (17% of original; P < .0001). In manual review, this was manifest as loss of cytoplasmic staining intensity with residual perinuclear staining. In precut slides that were vacuum sealed, IDH-1 did not show significant loss of epitope detection for any storage temperature through 1 year.
Discussion
In this study, we investigated optimal storage conditions of precut TMA slides by assessing variables in storage conditions, including temperature, vacuum sealing, and paraffin coating, and by using image analysis software to evaluate residual epitope detectability at multiple time points over a 1-year period. Novel findings in this study include the following: (1) with the important caveat of antibody-specific diversity, immunoreactivity was overall best preserved for slides stored at -20°C without paraffin coating. (2) Storage at a lower temperature (-80°C) did not have any added value in preserving immunoreactivity. (3) Although paraffin coating of precut slides is a common practice for storage, this consistently showed a detrimental effect on epitope detection. (4) Vacuum sealing was preservative for some epitopes but harmful for others. And finally, (5) the loss of immunoreactivity seen in our study-particularly for AR, Ki-67, and IDH-1-could compromise analysis of prognostic and predictive markers. Our findings corroborate recommendations suggested by the Canadian Association of Pathologists 14 and expand current knowledge with particular regard to ❚Image 1❚ (cont) G, H, Isocitrate dehydrogenase 1: time 0 vs week 12 refrigerated, exposed to air (×400, anaplastic astrocytoma). use of vacuum sealing, paraffin coating, and storage at low temperatures. This study is unique in its use of image analysis to objectively quantify loss of epitope detection at multiple points in two separate 1-year periods and its combined evaluation of various storage conditions available to the laboratory, including freezing (-20°C and -80°C), vacuum sealing, and paraffin coating. We believe the main value of the results of this study is in helping to inform storage of precut slides in (1) the clinical setting in which precut slides, often of a small biopsy, may be used for additional immunohistochemical studies when reviewed later at another institution or when new diagnostic, prognostic, or predictive markers become available and (2) the research setting in which a TMA is constructed and all slides cut at one time point to maximize the number of slides produced but may be stored for an uncertain period of time prior to immunohistochemical staining.
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Our evaluation of prognostic, predictive, and diagnostic markers quantifies the extent of loss of epitope detectability on precut slides and raises questions about the potential impact on patient management. For example, Ki-67 is a common prognostic marker in breast cancer that can be used in immunohistochemical recurrence scores and in evidence-based grading schemes for gastrointestinal and pancreatic endocrine neoplasms. [16] [17] [18] Although differences in H-scores did not reach statistical significance for many of the time and storage conditions for Ki-67, the entire TMA at 1 year showed a median H-score that ranged from 37% (precut slides stored with a paraffin coating) to 92% (precut slides stored at -20°C with vacuum sealing) of the time 0 value. Losses that could affect prognostic reporting, neuroendocrine neoplasm grading, and potentially classification of breast carcinoma were seen as early as 12 weeks (48% of original, paraffin coating). IDH-1 mutations are detected in approximately 80% of oligodendrogliomas with 1p/19q deletions and are a good prognostic indicator in patients with glioblastoma. 19 Although this antibody is interpreted in a binary fashion, precut stored slides exposed to air or paraffin coating may show diminished immunoreactivity, which could hinder interpretation. AR expression is prognostic in prostate 20 and breast cancers. 21 These carcinomas could show clinically relevant loss of reactivity for AR (falsely diminished staining) starting at approximately 6 months of storage, under various storage conditions. Finally, TP53 mutation is associated with poor prognosis in many malignancies, 22 and this antibody had the earliest and greatest loss of immunoreactivity. Loss of p53 staining could lead to inaccurate interpretation as either TP53 mutated or wild type. Partial loss of a p53 staining in a TP53-mutated neoplasm that was diffusely p53 positive could lead to an interpretation of a TP53 wild-type tumor. Conversely, the complete loss of wild-type p53 expression would lead to the inaccurate interpretation of TP53 mutant. This could have a significant impact on its utility as a diagnostic marker, particularly for Müllerian malignancies. Loss of epitope detection in prognostic and predictive markers-sometimes at a lower threshold than some diagnostic markers-may affect the laboratory's ability to inform patient treatment and outcome.
With regard to storage conditions, previous studies have demonstrated sometimes unpredictable loss of epitope detection related to specific antibodies on precut stored slides. Our study substantiates these findings and provides additional evidence for the detrimental effect of storing precut slides, particularly at warmer temperatures.
We also consistently found a harmful effect of paraffin coating of precut slides on tissue labeling with most antibodies used in this study. This corroborates findings from a previous analysis wherein Karlsson and Karlsson 12 showed significant loss of antigenicity immunoreactivity of p53 and CK7 at 1 year but contrasts findings from a TMA study on breast cancer specimens using Ki-67, ER, and cytokeratin, wherein protective effects of paraffin coating and storage in a nitrogen desiccator were demonstrated. 9 However, in the latter study, 5-mm sections were cut and then tape-transferred to adhesive slides, washed in xylene, and then dipped in melted paraffin, which was sometimes supplemented with an antioxidant (2,6-di-tertbutyl-4-methyl-phenol or 2[3]-t-butyl-4-hydroxyanisole). 9 These differences in paraffin coating procedures may in part explain the discrepancy in results between these two studies.
Comparing vacuum sealing vs exposure to air, one antibody (IDH-1) showed markedly better retention of reactivity at all temperature conditions when slides were stored in a vacuum-sealed container instead of exposed to ambient air. In contrast, p53 showed significant loss of epitope detection for both phases of our study, and the effect was more pronounced for precut slides stored in vacuum-sealed containers. Although not statistically significant, we were somewhat surprised by differences in results for IDH-1 with regard to apparent increases in immunoreactivity under vacuum-sealed conditions for some time points. The median H-score from the IDH-1 experiment with vacuum sealing was low, which could allow small changes to appear larger given the smaller denominator. In manual review of the IDH-1 stained glass slides, loss of immunoreactivity was easily visible, but the apparent increase in immunoreactivity was not readily detectable. IDH-1 was the most difficult antibody to quantify both manually and by image analysis due to the somewhat diffuse nature of glial cytoplasm (and thus the immunohistochemical staining) and the tendency for the antibody to show less cytoplasmic staining but persistent perinuclear staining over time. Thus, we think that vacuum sealing is protective for the IDH-1 epitope and may actually increase immunoreactivity, but that property may be overestimated by the findings in this study for the reasons listed above. This highlights potential challenges in image analysis for semiquantitative scoring for some antibodies.
A weakness in this study is the lack of easy generalizability to all immunohistochemical markers due to the antibody-specific diversity in results demonstrated in our study and in essentially all previous studies. Some important variables, such as formalin fixation time and exposure to light, were not specifically evaluated. We minimized temperature fluctuations within the experimental period, but this may not reflect laboratory practice for specimens such as precut controls, and the preservation of epitope detection seen at -20°C and -80°C may not be generalizable if these slides undergo multiple freeze/thaw cycles prior to use. We avoided these freeze/thaw cycles by keeping our slides in separate, five-slide containers that we retrieved as needed. Although slide/tissue section separation may happen more frequently with slides stored at -20°C, 23 we did not observe increased tissue/slide separation on our frozen slides. Intrinsic to most TMA studies, the tissue we studied is heterogeneous, and different percent positive staining is expected at different levels of the TMA; we minimized this effect by intentionally selecting more homogeneous neoplasms and by using robust statistical analyses. Some of the differences in results between slides stored at ambient air vs vacuum sealed may be related to differences in antibody lot, although the same antibody lot was used for all data points throughout both portions of the experiment for AR, synaptophysin, and p53; for IDH-1 and Ki-67, one antibody lot was used for the all data points in the ambient air experiment, and another antibody lot from the same manufacturer was used for all data points in the vacuum-sealing experimental portion. This new antibody was validated according to recommendations from the College of American Pathologists. Finally, we quantified the number of cells staining at different intensities within the entire tissue core by image analysis; this method does not focus on tumor "hotspots" and to some extent quantifies loss of epitope detection, which may not be diagnostically or clinically meaningful. However, we found this method more objective and reproducible than manual review and more reflective of overall immunoreactivity.
In conclusion, our study demonstrates a time, temperature, storage condition, and antibody-dependent loss of epitope detection on precut slides. Our findings support previous recommendations for thoughtful storage of these slides and suggest that the best storage conditions are at -20°C, without paraffin coating or vacuum sealing.
